Wednesday, January 24, 2018 10:15 PM ET
Significant Insider Selling in Shares of Biohaven Pharmaceutical Holding (BHVN) Continues
One Biohaven Pharmaceutical Holding insider Portage Biotech Inc, Required Filer, today, sold 59,396 shares having a market value of approximately $8,049,365,832, as disclosed in a form 4 document filed with the SEC. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 933,481 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 992,877 shares and have averaged 165,480 shares per transaction over this time period.
The number of insider buy/sell trades at Biohaven Pharmaceutical Holding is higher than that of the 191 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 161 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 26,245,628 shares purchased and 11,766,505 shares sold with company insiders having bought 127,010 shares on average over this time period.
The data sourced in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.